1Hartmann L.Risk assessment and risk reduction strategies:overview.The 31th Annual SABCS (San Antonio Breast Cancer Symposium).San Antonio,2008.10-14.
2Gail MH,Brinton LA,Byar DP,et al.Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.J Natl Cancer Inst,1989,81(24):1879-1886.
3Ghosh K,Pankratz VS,Reynolds CA,et al.Benign breast disease and breast cancer risk in young women.The 31th Annual SABCS (San Antonio Breast Cancer Symposium).San Antonio,2008.10-14.
4Wishart GC,Warwick J,Pitsinis V,et al.Measuring performance in clinical breast examination.Br J Surg,2010,97:1246-1252.
5Pugh CM,Domont ZB,Salud LH,et al.A simulation-based assessment of clinical breast examination technique:do patient and clinician factors affect clinician approach? Am J Surg,2008,195:874-880.
6Whiffen A,El-Tamer M,Taback B,et al.Predictors of Breast Cancer Development in Women with Atypical Ductal Hyperplasia and Atypical Lobular Hyperplasia.Ann Surg Oncol,2010,28:[Epub ahead of print].
7Cangiarella J,Guth A,Axelrod D,et al.Necessity of surgical excision for atypical lobular hyperplasia and lobular carcinoma in situ.Arch Pathol Lab Med,2009,133:511.
